United States · FDA National Drug Code directory
bendamustine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16729-250_1d8759d2-4d4d-78ee-e063-6294a90a53ae
- Product NDC
- 16729-250
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- bendamustine hydrochloride
- Labeler
- Accord Healthcare, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221207
- Source listing expiry
- 20261231
Source-listed ingredients
- BENDAMUSTINE HYDROCHLORIDE — 25 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (16729-250-03) / 5 mL in 1 VIAL, SINGLE-DOSE · 16729-250-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →